| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Pathology, National Cancer Institute [L. V. D., Z. Z., M. R. E-B., L. A. L., I. A. L.], National Center for Human Genome Research [S. C. C., P. M., S. C. G., F. S. C.], and Branches of Metabolic Diseases [S. J. M., A. M. S.], Diabetes [M. C. S.], and Digestive Diseases [R. T. J.], National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland 20892
Endocrine tumors (ETs) of pancreas and duodenum occur sporadically and as a part of multiple endocrine neoplasia type 1 (MEN1). The MEN1 tumor suppressor gene has been localized to chromosome 11q13 by link-age analysis but has not yet isolated. Previous allelic deletion studies in enteropancreatic ETs suggested MEN1 gene involvement in tumorigenesis of familial pancreatic ETs (nongastrinomas) and sporadic gastrinomas. However, only a few MEN1-associated duodenal gastrinomas and sporadic pancreatic nongastrinomas have been investigated. We used tissue microdissection to analyze 95 archival pancreatic and duodenal ETs and metastases from 50 patients for loss of heterozygosity (LOH) on 11q13 with 10 polymorphic markers spanning the area of the putative MEN1 gene. Chromosome 11q13 LOH was detected in 23 of 27 (85%) MEN1-associated pancreatic ETs (nongastrinomas), 14 of 34 (41%) MEN1-associated gastrinomas, 3 of 16 (19%) sporadic insulinomas, and 8 of 18 (44%) sporadic gastrinomas. Analysis of LOH on 11q13 showed different deletion patterns in ETs from different MEN1 patients and in multiple tumors from individual MEN1 patients. The present results suggest that the MEN1 gene plays a role in all four tumor types. The lower rate of 11q13 LOH in MEN1-associated and sporadic gastrinomas and sporadic insulinomas as compared to MEN1 nongastrinomas may reflect alternative genetic pathways for the development of these tumors or mechanisms of the MEN1 gene inactivation that do not involve large deletions. The isolation of the MEN1 gene is necessary to further define its role in pathogenesis of pancreatic and duodenal ETs.
1 To whom requests for reprints should be addressed, at Laboratory of Pathology, National Cancer Institute, NIH. Building 10, Room 2N212, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 496-0549; Fax: (301) 480-9488.
Received 11/11/96. Accepted 4/ 4/97.
This article has been cited by other articles:
![]() |
M. M. Hassan, A. Phan, D. Li, C. G. Dagohoy, C. Leary, and J. C. Yao Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 959 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hussein, J. Lu, H. Casse, S. Fontaniere, A.-M. Morera, S. M. Guittot, A. Calender, N. Di Clemente, and C. X Zhang Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-{beta} pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice Endocr. Relat. Cancer, March 1, 2008; 15(1): 217 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Korsisaari, J. Ross, X. Wu, M. Kowanetz, N. Pal, L. Hall, J. Eastham-Anderson, W. F. Forrest, N. Van Bruggen, F. V. Peale, et al. Blocking Vascular Endothelial Growth Factor-A Inhibits the Growth of Pituitary Adenomas and Lowers Serum Prolactin Level in a Mouse Model of Multiple Endocrine Neoplasia Type 1 Clin. Cancer Res., January 1, 2008; 14(1): 249 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-H. Jiang, J.-L. Lu, B. Cui, Y.-J. Zhao, W.-q. Wang, J.-M. Liu, W.-Q. Fang, Y.-N. Cao, Y. Ge, C.-x. Zhang, et al. MEN1 mutation analysis in Chinese patients with multiple endocrine neoplasia type 1 Endocr. Relat. Cancer, December 1, 2007; 14(4): 1073 - 1079. [Abstract] [Full Text] [PDF] |
||||
![]() |
D M Pritchard Pathogenesis of gastrinomas associated with multiple endocrine neoplasia type 1 Gut, May 1, 2007; 56(5): 606 - 607. [Full Text] [PDF] |
||||
![]() |
M Anlauf, A Perren, T Henopp, T Rudolf, N Garbrecht, A Schmitt, A Raffel, O Gimm, E Weihe, W T Knoefel, et al. Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions Gut, May 1, 2007; 56(5): 637 - 644. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Perren, M. Anlauf, T. Henopp, T. Rudolph, A. Schmitt, A. Raffel, O. Gimm, E. Weihe, W. T. Knoefel, H. Dralle, et al. Multiple Endocrine Neoplasia Type 1 (MEN1): Loss of One MEN1 Allele in Tumors and Monohormonal Endocrine Cell Clusters But Not in Islet Hyperplasia of the Pancreas J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1118 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Asgharian, Y.-J. Chen, N. J. Patronas, P. L. Peghini, J. C. Reynolds, A. Vortmeyer, Z. Zhuang, D. J. Venzon, F. Gibril, and R. T. Jensen Meningiomas May Be a Component Tumor of Multiple Endocrine Neoplasia Type 1 Clin. Cancer Res., February 1, 2004; 10(3): 869 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Furlan, R. Cerutti, S. Uccella, S. La Rosa, E. Rigoli, A. Genasetti, and C. Capella Different Molecular Profiles Characterize Well-Differentiated Endocrine Tumors and Poorly Differentiated Endocrine Carcinomas of the Gastroenteropancreatic Tract Clin. Cancer Res., February 1, 2004; 10(3): 947 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bertolino, W.-M. Tong, D. Galendo, Z.-Q. Wang, and C.-X. Zhang Heterozygous Men1 Mutant Mice Develop a Range of Endocrine Tumors Mimicking Multiple Endocrine Neoplasia Type 1 Mol. Endocrinol., September 1, 2003; 17(9): 1880 - 1892. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bertolino, W.-M. Tong, P. L. Herrera, H. Casse, C. X. Zhang, and Z.-Q. Wang Pancreatic {beta}-Cell-specific Ablation of the Multiple Endocrine Neoplasia Type 1 (MEN1) Gene Causes Full Penetrance of Insulinoma Development in Mice Cancer Res., August 15, 2003; 63(16): 4836 - 4841. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Gibril, Y.-J. Chen, D. S. Schrump, A. Vortmeyer, Z. Zhuang, I. A. Lubensky, J. C. Reynolds, A. Louie, L. K. Entsuah, K. Huang, et al. Prospective Study of Thymic Carcinoids in Patients with Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1066 - 1081. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Guo and M. P. Sawicki Molecular and Genetic Mechanisms of Tumorigenesis in Multiple Endocrine Neoplasia Type-1 Mol. Endocrinol., October 1, 2001; 15(10): 1653 - 1664. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bordi, V. D. Corleto, C. Azzoni, S. Pizzi, G. Ferraro, F. Gibril, G. Delle Fave, and R. T. Jensen The Antral Mucosa as a New Site for Endocrine Tumors in Multiple Endocrine Neoplasia Type 1 and Zollinger-Ellison Syndromes J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2236 - 2242. [Abstract] [Full Text] |
||||
![]() |
C. A. Stratakis, D. H. Schussheim, S. M. Freedman, M. F. Keil, S. D. Pack, S. K. Agarwal, M. C. Skarulis, R. J. Weil, I. A. Lubensky, Z. Zhuang, et al. Pituitary Macroadenoma in a 5-Year-Old: An Early Expression of Multiple Endocrine Neoplasia Type 1 J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4776 - 4780. [Abstract] [Full Text] |
||||
![]() |
J. Serrano, S. U. Goebel, P. L. Peghini, I. A. Lubensky, F. Gibril, and R. T. Jensen Alterations in the p16INK4a/CDKN2A Tumor Suppressor Gene in Gastrinomas J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4146 - 4156. [Abstract] [Full Text] |
||||
![]() |
F. Yu, R. T. Jensen, I. A. Lubensky, E. H. Mahlamaki, Y.-L. Zheng, A. M. Herr, and L. J. Ferrin Survey of Genetic Alterations in Gastrinomas Cancer Res., October 1, 2000; 60(19): 5536 - 5542. [Abstract] [Full Text] |
||||
![]() |
S. U. Goebel, A. O. Vortmeyer, Z. Zhuang, J. Serrano, R. T. Jensen, and I. A. Lubensky Identical Clonality of Sporadic Gastrinomas at Multiple Sites Cancer Res., January 1, 2000; 60(1): 60 - 63. [Abstract] [Full Text] |
||||
![]() |
E. C. Wooten, D. Fults, R. Duggirala, K. Williams, A. P. Kyritsis, M. L. Bondy, V. A. Levin, and P. O'Connell A study of loss of heterozygosity at 70 loci in anaplastic astrocytoma and glioblastoma multiforme with implications for tumor evolution Neuro-oncol, July 1, 1999; 1(3): 169 - 176. [Abstract] [PDF] |
||||
![]() |
D. Gisselsson, M. Hoglund, F. Mertens, P. Dal Cin, and N. Mandahl Hibernomas are Characterized by Homozygous Deletions in the Multiple Endocrine Neoplasia Type I Region : Metaphase Fluorescence in Situ Hybridization RevealsComplex Rearrangements Not Detected by Conventional Cytogenetics Am. J. Pathol., July 1, 1999; 155(1): 61 - 66. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Gortz, J. Roth, A. Krahenmann, R. R. de Krijger, S. Muletta-Feurer, K. Rutimann, P. Saremaslani, E. J. M. Speel, P. U. Heitz, and P. Komminoth Mutations and Allelic Deletions of the MEN1 Gene Are Associated with a Subset of Sporadic Endocrine Pancreatic and Neuroendocrine Tumors and Not Restricted to Foregut Neoplasms Am. J. Pathol., February 1, 1999; 154(2): 429 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. O. Vortmeyer, R. Boni, S. D. Pack, T. N. Darling, and Z. Zhuang Perivascular Cells Harboring Multiple Endocrine Neoplasia Type 1 Alterations Are Neoplastic Cells in Angiofibromas Cancer Res., January 1, 1999; 59(2): 274 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Asa, K. Somers, and S. Ezzat The MEN-1 Gene Is Rarely Down-Regulated in Pituitary Adenomas J. Clin. Endocrinol. Metab., September 1, 1998; 83(9): 3210 - 3212. [Abstract] [Full Text] |
||||
![]() |
C. Tanaka, T. Kimura, P. Yang, M. Moritani, T. Yamaoka, S. Yamada, T. Sano, K. Yoshimoto, and M. Itakura Analysis of Loss of Heterozygosity on Chromosome 11 and Infrequent Inactivation of the MEN1 Gene in Sporadic Pituitary Adenomas J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2631 - 2634. [Abstract] [Full Text] |
||||
![]() |
S. C. Guru, S. K. Agarwal, P. Manickam, S.-E. Olufemi, J. S. Crabtree, J. M. Weisemann, M. B. Kester, Y. S. Kim, Y. Wang, M. R. Emmert-Buck, et al. A Transcript Map for the 2.8-Mb Region Containing the Multiple Endocrine Neoplasia Type 1 Locus Genome Res., July 1, 1997; 7(7): 725 - 735. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |